Table 3.
Survivors |
Non-survivors |
P -value | |
---|---|---|---|
(n = 43) | (n = 29) | ||
Disseminated intravascular coagulation (DIC) |
10/43 (23%) |
9/29 (31%) |
0.59 |
ISTH score |
3 (1, 4) |
4 (2, 5) |
0.67 |
Platelet count, G/l |
65 (20, 184) |
87 (47, 195) |
0.30 |
ADAMTS13 activity <30% |
17/43 (37%) |
19/29 (66%) |
0.05 |
ADAMTS13 activity <5% |
1/43 |
3/29 |
- |
ADAMTS13:Ag, ng/mL |
483 (384, 613) |
491 (418, 696) |
0.24 |
VWF:Ag, % |
477 (341, 656) |
560 (478, 835) |
0.05 |
IL-6, pg/mL | 107 (48, 418) | 840 (204, 1089) | 0.03 |
Values are expressed as median and interquartile range for continuous variables and as number and proportion for categorical variables. Continuous variables were compared using the non-parametric Mann–Whitney U-test. Categorical variables were compared using the χ2 test. P <0.05 was considered significant. ISTH, International Society for Thrombosis and Haemostasis; ADAMTS13, a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13; ADAMTS13:Ag, ADAMTS13 antigen; VWF:Ag, von Willebrand Factor antigen.